Sustained release drug delivery devices

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424422, 424424, 424427, 424468, 424425, 6048901, 6048911, 6048921, A61K9/22

Patent

active

059025980

ABSTRACT:
A method and device for treating a mammalian organism to obtain a desired local or systemic physiological or pharmacological effect is provided. The method includes administering a sustained release drug delivery system to a mammalian organism in need of such treatment at an area wherein release of an effective agent is desired and allowing the effective agent to pass through the device in a controlled manner. The device includes an inner core or reservoir comprising the effective agent; a first coating layer, which is permeable to the passage of the effective agent; a second coating layer, which is essentially impermeable to the passage of the effective agent; and a third coating layer, which is permeable to the passage of the effective agent. The first coating layer covers at least a portion of the inner core. The second coating layer covers at least a portion of the first coating layer and inner core; however, at least a small portion of the first coating layer or inner core is not coated with the second coating layer. The second coating layer includes an impermeable film and at least one impermeable disc. The third coating layer essentially completely covers the second coating layer and the uncoated portion of the first coating layer or inner core.

REFERENCES:
patent: 3416530 (1968-12-01), Ness
patent: 3618604 (1971-11-01), Ness
patent: 3630200 (1971-12-01), Higuchi
patent: 3632739 (1972-01-01), Kornblum
patent: 3896819 (1975-07-01), Zaffaroni et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 3961628 (1976-06-01), Arnold
patent: 3977404 (1976-08-01), Theeuwes
patent: 3980463 (1976-09-01), Muramoto et al.
patent: 3993071 (1976-11-01), Higuchi et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 4014334 (1977-03-01), Theeuwes et al.
patent: 4014335 (1977-03-01), Arnold
patent: 4034758 (1977-07-01), Theeuwes
patent: 4036227 (1977-07-01), Zaffaroni et al.
patent: 4077407 (1978-03-01), Theeuwes et al.
patent: 4111201 (1978-09-01), Theeuwes
patent: 4111203 (1978-09-01), Theeuwes
patent: 4135514 (1979-01-01), Zaffaroni et al.
patent: 4142526 (1979-03-01), Zaffaroni et al.
patent: 4186184 (1980-01-01), Zaffaroni
patent: 4200098 (1980-04-01), Ayer et al.
patent: 4247498 (1981-01-01), Castro
patent: 4256108 (1981-03-01), Theeuwes
patent: 4290426 (1981-09-01), Luschen et al.
patent: 4326525 (1982-04-01), Swanson et al.
patent: 4327725 (1982-05-01), Cortese et al.
patent: 4439196 (1984-03-01), Higuchi
patent: 4475916 (1984-10-01), Higuchi
patent: 4519801 (1985-05-01), Edgren
patent: 4519909 (1985-05-01), Castro
patent: 4522625 (1985-06-01), Edgren
patent: 4609374 (1986-09-01), Ayer
patent: 4615698 (1986-10-01), Guitard et al.
patent: 4624847 (1986-11-01), Ayer et al.
patent: 4627850 (1986-12-01), Deters et al.
patent: 4652441 (1987-03-01), Okada et al.
patent: 4657543 (1987-04-01), Langer et al.
patent: 4673405 (1987-06-01), Guittard et al.
patent: 4681755 (1987-07-01), Columbo et al.
patent: 4692336 (1987-09-01), Eckenhoff et al.
patent: 4693886 (1987-09-01), Ayer
patent: 4711782 (1987-12-01), Okada et al.
patent: 4716031 (1987-12-01), Eckenhoff et al.
patent: 4717567 (1988-01-01), Wu et al.
patent: 4720384 (1988-01-01), Di Luccio et al.
patent: 4730013 (1988-03-01), Bondi et al.
patent: 4777049 (1988-10-01), Magruder et al.
patent: 4786500 (1988-11-01), Wong
patent: 4806382 (1989-02-01), Goldberg et al.
patent: 4832957 (1989-05-01), Dempski et al.
patent: 4839177 (1989-06-01), Columbo et al.
patent: 4861627 (1989-08-01), Mathiowitz et al.
patent: 4865846 (1989-09-01), Kaufman
patent: 4877618 (1989-10-01), Reed, Jr.
patent: 4882150 (1989-11-01), Kaufman
patent: 4889720 (1989-12-01), Konishi
patent: 4891223 (1990-01-01), Ambegaonkar et al.
patent: 4898733 (1990-02-01), DePrince et al.
patent: 4913906 (1990-04-01), Friedman et al.
patent: 4927687 (1990-05-01), Nuwayser
patent: 4952402 (1990-08-01), Sparks et al.
patent: 4994273 (1991-02-01), Aentner et al.
patent: 5028435 (1991-07-01), Katz et al.
patent: 5091185 (1992-02-01), Castillo et al.
patent: 5098443 (1992-03-01), Parel et al.
patent: 5141752 (1992-08-01), Ayer et al.
patent: 5378475 (1995-01-01), Smith et al.
patent: 5435998 (1995-07-01), Abelson
patent: 5665373 (1997-09-01), Robertson et al.
Database WPI, Week 7943, Derwent Publications Ltd., London, GB; AN 79-78139b XP002065720 & JP 54 119 021 (Nippon Kayaku KK), Sep. 14, 1979.
Blandford et al., 5-Fluorouracil Sustained Release Device Implantation: Toxicology and Histology in Rabbits, Invest. Opthal. And Vis. Sci. 31(4):591, abstr. 2893-89 (1990).
Goins et al., Intravitreal Sustained Release of Gancyclovir, Invest. Opthal. And Vis. Sci. 31(4):364, abstr. 1791 (1990).
Pearson et al., Polyvinyl Alcohol Membrane Permeability Characteristics of Gancyclovir, Invest. Opthal. And Vis. Sci. 30(4):511, abstr. 42 (1989).
Smith et al., Polyvinyl Alcohol Membrane Permeability Characteristics of 5-Fluorouracil, Journal of Ocular Pharmacology, 4(2):147-152, (1988).
Smith et al., Intraocular Sustained Release of Antiviral Agents in AIDS, Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 17:470-471 (1990).
Smith et al., A Membrane Based Sustained Release Ocular Delivery System for 5-Fluorouracil, Invest. Opthal. And Vis. Sci. 30(4):271, abstr. 37 (1989).
Solomon et al., Sustained Release Drug Delivery Systems in Extracapsular Cataract Surgery, Invest. Opthal. And Vis. Sci., 31(4):351, Abstr. 1724-19 (1990).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Sustained release drug delivery devices does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release drug delivery devices, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release drug delivery devices will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-244522

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.